drugset / Trial / NCT02645253
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
RandomizedParallel-groupSingle-blindBasic science
Summary
This is a randomized, single-blind, placebo-controlled, sequential-group study to assess the safety and tolerability as well as how the drug (AZD7594) affects the body (pharmacodynamics \[PD\]) and how the body affects the drug (pharmacokinetics \[PK\]) when AZD7594 is given as single and multiple ascending doses once daily by inhalation to healthy male Japanese subjects, compared with placebo (non-active drug)
Timeline
- Start
- 2016-01-12
- Primary completion
- 2016-04-17
- Completion
- 2016-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VELSECORAT | Other / unclassified | 200 ug | Inhaled |
| Subject | VELSECORAT | Other / unclassified | 400 ug | Inhaled |
| Subject | VELSECORAT | Other / unclassified | 1600 ug | Inhaled |